Segall Bryant & Hamill’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-25,746
Closed -$2.06M 571
2016
Q4
$2.06M Sell
25,746
-8,000
-24% -$635K 0.05% 287
2016
Q3
$2.69M Sell
33,746
-250
-0.7% -$20.2K 0.07% 256
2016
Q2
$2.65M Sell
33,996
-6,807
-17% -$485K 0.07% 262
2016
Q1
$2.24M Sell
40,803
-230
-0.6% -$12.5K 0.06% 287
2015
Q4
$2.54M Sell
41,033
-163
-0.4% -$10.3K 0.06% 275
2015
Q3
$2.6M Sell
41,196
-1,374
-3% -$98.1K 0.06% 281
2015
Q2
$3.11M Sell
42,570
-2,047
-5% -$148K 0.07% 279
2015
Q1
$2.92M Sell
44,617
-3,447
-7% -$229K 0.07% 278
2014
Q4
$3.13M Sell
48,064
-2,114
-4% -$136K 0.07% 274
2014
Q3
$3.02M Sell
50,178
-7,444
-13% -$486K 0.07% 267
2014
Q2
$3.99M Sell
57,622
-4,640
-7% -$301K 0.1% 215
2014
Q1
$4.07M Sell
62,262
-290
-0.5% -$18.9K 0.1% 217
2013
Q4
$3.88M Sell
62,552
-1,664
-3% -$96.4K 0.09% 217
2013
Q3
$3.44M Sell
64,216
-15,888
-20% -$818K 0.09% 225
2013
Q2
$3.65M Buy
+80,104
New +$3.47M 0.1% 209

Other funds holding STJ

Segall Bryant & Hamill's STJ Position: Q1 2017 in Review

Segall Bryant & Hamill sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 25,746 shares — an estimated $2.06M sold.

Segall Bryant & Hamill first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $4.07M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Segall Bryant & Hamill reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Segall Bryant & Hamill sold 25,746 St Jude Medical shares in Q1 2017, an estimated $2.06M.
  • Segall Bryant & Hamill first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Segall Bryant & Hamill's St Jude Medical position peaked at $4.07M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Segall Bryant & Hamill's 13F filing for Q1 2017, filed 12 May 2017.